The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway

International Journal of Radiation Biology

Volumn 89, Issue 12, 2013, Pages 1079-1086

  Lei, Yu ^a   Li, Hong Xia ^b   Jin, Wen Sen ^a   Peng, Wan Ren ^a   Zhang, Cong Jun ^a   Bu, Li Jia ^a   Du, Ying Ying ^a   Ma, Tai ^a   Sun, Guo Ping ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Department of Plastic Surgery   (China)

Author keywords

Apoptosis; Lung cancer; Paeonol; PI3K Akt pathway; Radiosensitization

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLOOXYGENASE 2; PEONOL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER TRANSPLANTATION; CARCINOMA CELL; CELL VIABILITY; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LETHAL DOSE; LEWIS CARCINOMA; LUNG ADENOCARCINOMA; MALE; MONOTHERAPY; MOUSE; MTT ASSAY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR MODEL; WESTERN BLOTTING;

EID: 84890935214     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2013.825058     Document Type: Article

References (35)

1. Bartholomeusz C, Gonzalez-Angulo AM. 2012. Targeting the PI3K signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets 16: 121-130
2. Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA, Robe P, Nestler U, Song Q, Loeffl er J. 2004. Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms. Oncogene 23 : 7494-7506
3. Chun YJ, Park IC, Park MJ, Woo SH, Hong SI, Chung HY, Kim TH, Lee YS, Rhee CH, Lee SJ. 2002. Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3). FEBS Letters 519 : 195-200
4. De Oliveira AC, Candelario-Jalil E, Langbein J, Wendeburg L, Bhatia HS, Schlachetzki JC, Biber K, Fiebich BL. 2012. Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia. Journal of Neuroinfl ammation 9 : 2-9
5. Fang ZH, Li YJ, Chen Z, Wang JJ, Zhu LH. 2013. Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells. International Journal of Gynecological Cancer 23 : 608-614
6. He Z, Subramaniam D, Ramalingam S, Dhar A, Postier RG, Umar S, Zhang Y, Anant S. 2011. Honokiol radiosensitizes colorectal cancer cells: Enhanced activity in cells with mismatch repair defects. American Journal of Physiology-Gastrointestinal and Liver Physiology 301 : G929-937
7. Hou GJ, Miao F. 2008. The empirical study on acute toxicity and antineoplastic activity of Paeonol. Journal of Heze Medical College 20: 27-29
8. Huang KF, Zhang GD, Huang YQ, Diao Y. 2012. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. International Immunopharmacology 12 : 334-341
9. Langer CJ. 2012. Individualized therapy for patients with non-small cell lung cancer: Emerging trends and challenges. Critical Reviews in Oncology/Hematology 83 : 130-144
10. Li N, Fan LL, Sun GP, Wan XA, Wang ZG, Wu Q, Wang H. 2010. Paeonol inhibits tumor growth in gastric cancer in vitro and in vivo. World Journal of Gastroenterology 16 : 4483-4490
11. Liu CY, Chang HS, Chen IS, Chen CJ, Hsu ML, Fu SL, Chen YJ. 2011. Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells. Radiation Oncology 6 : 56-63
12. Liu Y, Cui B, Qiao Y, Zhang Y, Tian Y, Jiang J, Ma D, Kong B. 2011. Phosphoinositide-3-kinase inhibition enhances radiosensitization of cervical cancer in vivo. International Journal of Gynecological Cancer 21 : 100-105
13. Louren ç o AM, Ferreira LM, Branco PS. 2012. Molecules of natural origin, semi-synthesis and synthesis with anti-infl ammatory and anticancer utilities. Current Pharmaceutical Design 18 : 3979-4046
14. Mimura K, Baba S. 1981. Determination of Paeonol metabolites in man by the use of stable isotopes. Chemical & Pharmaceutical Bulletin 29 : 2043-2050
15. Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P. 2013. Intensity-modulated radiation therapy with concurrent chemotherapy for anal cancer: Outcomes and toxicity. American Journal of Clinical Oncology [Epub ahead of print].
16. Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, Fulda S. 2008. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor-And drug-induced apoptosis. Cancer Research 68: 6271-6280
17. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, Bao JK. 2012 Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Proliferation 45 : 487-498
18. Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS. 2011 .® -Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Letters 312 : 178-188
19. Pennati M, Binda M, Colella G, Folini M, Citti L, Villa R, Daidone MG, Zaff aroni N. 2003. Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. Journal of Investigative Dermatology 120: 648-654
20. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W. 2010. Chinese herbal medicines as adjuvant treatment during chemo-or radiotherapy for cancer. Bioscience Trends 4: 297-307
21. Raghavan P, Tumati V, Yu L, Chan N, Tomimatsu N, Burma S, Bristow RG, Saha D. 2012. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells. International Journal of Radiation Oncology Biology Physics 84 : E507-514
22. Raju U, Ariga H, Dittmann K, Nakata E, Ang KK, Milas L. 2005. Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib. International Journal of Radiation Oncology Biology Physics 63: 520-528
23. Riley CM, Ren TC. 1989. Simple method for the determination of Paeonol in human and rabbit plasma by high-performance liquid chromatography using solid-phase extraction and ultraviolet detection. Journal of Chromatography 489 : 432-437
24. Rygaard K, Spang-Th omsen M. 1997. Quantitation and gompertzian analysis of tumor growth. Breast Cancer Research and Treatment 46 : 303-312
25. Rödel F, Hoff mann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R, Rödel C. 2005. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Research 65: 4881-4887
26. Sankari SL, Masthan KM, Babu NA, Bhattacharjee T, Elumalai M. 2012. Apoptosis in cancer-An update. Asian Pacifi c Journal of Cancer Prevention 13: 4873-4878
27. Shewach DS, Lawrence TS. 2007. Antimetabolite radiosensitizers. Journal of Clinical Oncology 25 : 4043-4050
28. Sun GP, Wang H, Xu SP, Shen YX, Wu Q, Chen ZD, Wei W. 2008a. Antitumor effects of Paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNFalpha production. European Journal of Pharmacology 584: 246-252
29. Sun GP, Wan X, Xu SP, Wang H, Liu SH, Wang ZG. 2008b. Antiproliferation and apoptosis induction of Paeonol in human esophageal cancer cell lines. Diseases of the Esophagus 21: 723-729
30. Th omas SR, Khuntia D. 2011. Motexafi n gadolinium: A promising radiation sensitizer in brain metastasis. Expert Opinion on Drug Discovery 6 : 195-203
31. Wang AH, Tian XY, Yu JJ, Mi JQ, Liu H, Wang RF. 2012. Celecoxib radiosensitizes the human cervical cancer HeLa cell line via a mechanism dependent on reduced cyclo-oxygenase-2 and vascular endothelial growth factor C expression. Journal of International Medical Research 40: 56-66
32. Willems L, Tamburini J, Chapuis N, Lacombe C, Mayeux P, Bouscary D. 2012. PI3K and mTOR signaling pathways in cancer: New data on targeted therapies. Current Oncology Reports 14: 129-138
33. Xia S, Zhao Y, Yu S, Zhang M. 2010. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells. Cancer Biotherapy and Radiopharmaceuticals 25: 317-323
34. Xu SP, Sun GP, Shen YX, Wei W, Peng WR, Wang H. 2007. Antiproliferation and apoptosis induction of Paeonol in HepG2 cells. World Journal of Gastroenterology 13 : 250-256
35. Zhang T, Cui GB, Zhang J, Zhang F, Zhou YA, Jiang T, Li XF. 2010. Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation. Oncology Reports 24: 1683-1689